经皮微波消融与骨水泥成形术:治疗疼痛性椎外骨转移瘤及骨髓瘤的临床价值
回顾性分析65例患者77个椎外骨肿瘤行影像引导微波消融联合骨水泥成形术,术后视觉模拟量表评分从术前6.32降至24小时1.01、2-4周1.71、20-24周2.01;20-24周随访影像显示65例中42例(64.6%)无局部进展,无手术相关并发症。
要点
- 微波消融联合骨水泥成形术可缓解椎外骨转移瘤所致疼痛,视觉模拟量表评分术后24小时即明显下降。
- 20-24周随访影像示65例中42例(64.6%)无局部进展,作者认为该技术对寡转移(局限播散)病的局部区域控制有前景。
- 全部77个肿瘤均实现完全、成功的消融,未报告手术相关并发症。
核心结论
- 微波消融可有效缓解骨转移瘤所致疼痛,并对转移瘤的局部区域控制具有前景,尤其在寡转移(局限播散)病的背景下。
研究设计与样本
- 回顾性研究纳入65例患者(男35例、女30例)共77个肿瘤,在一家三级转诊学术中心接受影像引导微波消融与骨水泥成形术,时间跨度为18个月。
- 术前及术后24小时、2-4周、20-24周采用视觉模拟量表评估手术疗效,随访横断面影像评估局部区域控制。
关键影像表现/征象
- 77个肿瘤位置:髂骨38个、髋臼上区23个、股骨5个、肱骨4个、肩部4个、胸骨3个。
- 肿瘤类型:多发性骨髓瘤15个,结肠癌转移9个、肺癌转移15个、乳腺癌转移12个、甲状腺癌转移7个、前列腺癌转移3个、肾癌转移4个。
- 全部77个肿瘤均实现完全、成功的消融,平均消融时间6分15秒(标准差12秒),平均使用能量5.49(标准差2.97)kJ。
- 平均视觉模拟量表评分:术前6.32(标准差1.94),术后24小时1.01(标准差1.24),术后2-4周1.71(标准差1.31),术后20-24周2.01(标准差1.42)。
- 20-24周随访影像显示65例患者中42例(64.6%)无局部进展;6例患者在术后24-52周死亡;未报告手术相关并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this study was to review the efficacy and durability of pain control and local tumor control using microwave ablation and cementoplasty in treating extraspinal osseous tumors. Painful osseous metastases are a common cause of cancer-related morbidity. Percutaneous thermal ablation presents an attractive minimally invasive option in this vulnerable patient group. MATERIALS AND METHODS. A retrospective review included 65 patients (35 men, 30 women) with 77 tumors who underwent image-guided microwave ablation and cementoplasty at a tertiary referral academic center over 18 months. Procedural efficacy was determined with a visual analog scale before the procedure and 24 hours, 2-4 weeks, and 20-24 weeks after the procedure. Locoregional control was assessed at follow-up cross-sectional imaging. RESULTS. The 77 tumors were in the following locations: ilium, 38; acetabulum on supraacetabular region, 23; femur, five; humerus, four; shoulder, four; sternum, three. The tumors were 15 multiple myelomas and metastases from cancers of the following organs: colon, nine; lung, 15; breast, 12; thyroid, seven; prostate, three; and kidney, four. Complete, successful ablation of all 77 tumors was achieved. Mean ablation time was 6 minutes 15 seconds (SD, 12 seconds), and mean energy used was 5.49 (SD, 2.97) kJ. The mean visual analog scale scores were 6.32 (SD, 1.94) before the procedure, 1.01 (SD, 1.24) at 24 hours, 1.71 (SD, 1.31) at 2-4 weeks, and 2.01 (SD, 1.42) at 20-24 weeks. Follow-up imaging at 20-24 weeks showed no local progression in 42 of 65 patients (64.6%). Six patients died 24-52 weeks after the procedure. No procedure-related complications were reported. CONCLUSION. Microwave ablation is efficacious in alleviating pain due to osseous metastases. The modality has promise for locoregional control of metastases, particularly in the context of oligometastatic (limited disseminated) disease.
引用
- Deib G, Deldar B, Hui F, et al. Percutaneous Microwave Ablation and Cementoplasty: Clinical Utility in the Treatment of Painful Extraspinal Osseous Metastatic Disease and Myeloma. AJR Am J Roentgenol. 2019. PMID: 30917019. doi:10.2214/AJR.18.20386
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。